Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.

[1]  P. Hopkins,et al.  Familial Aggregation of Low-Renin Hypertension , 2002, Hypertension.

[2]  F. Frey,et al.  In Vivo 11&bgr;-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice , 2001, Hypertension.

[3]  M. Caulfield,et al.  Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11β‐hydroxysteroid dehydrogenase to hypertension in Black people , 2001, Clinical endocrinology.

[4]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[5]  F. Frey,et al.  Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease , 2000 .

[6]  P. Manunta,et al.  CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity. , 2000, Hypertension.

[7]  F. Veglio,et al.  CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. , 2000, Hypertension.

[8]  G. Giacchetti,et al.  Genotype-Phenotype Correlations of Mutations and Polymorphisms in HSD11B2, the Gene Encoding the Kidney Isozyme of 11β-Hydroxysteroid Dehydrogenase , 2000 .

[9]  F. Frey,et al.  Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  N. Glorioso,et al.  The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. , 1999, Hypertension.

[11]  F. Cambien,et al.  Structural analysis and evaluation of the 11β‐hydroxysteroid dehydrogenase type 2 (11β‐HSD2) gene in human essential hypertension , 1998, Journal of Hypertension.

[12]  M. New,et al.  A genetic defect resulting in mild low-renin hypertension. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Laragh,et al.  Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. , 1998, American journal of hypertension.

[14]  F. Frey,et al.  A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. , 1998, The Journal of clinical endocrinology and metabolism.

[15]  T. Fujii,et al.  Sodium sensitivity and cardiovascular events in patients with essential hypertension , 1997, The Lancet.

[16]  C. Shackleton,et al.  Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state , 1997, Journal of hypertension.

[17]  T. Mune,et al.  11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess , 1997 .

[18]  A. Piazza,et al.  Genetic analysis of Sardinia: I. Data on 12 polymorphisms in 21 linguistic domains , 1996, Annals of human genetics.

[19]  M. Reidenberg,et al.  Grapefruit juice and its flavonoids inhibit 11β‐hydroxysteroid dehydrogenase , 1996 .

[20]  T. Mune,et al.  Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. , 1995, Genomics.

[21]  T. Mune,et al.  Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase , 1995, Nature Genetics.

[22]  J. Mason,et al.  Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. , 1994, The Journal of clinical endocrinology and metabolism.

[23]  A. Piazza.  Who are the Europeans? , 1993, Science.

[24]  D. Housman,et al.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.

[25]  J. Funder,et al.  Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  N. Glorioso,et al.  Evidence of Coexisting Changes in 11β-Hydroxysteroid Dehydrogenase and 5β-Reductase Activity in Subjects With Untreated Essential Hypertension , 1995 .

[27]  A. Piazza,et al.  Human Genomic Diversity in Europe: A Summary of Recent Research and Prospects for the Future , 1993, European journal of human genetics : EJHG.